FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078097741> ?p ?o ?g. }

• W2078097741 endingPage "e52984" @default.
• W2078097741 startingPage "e52984" @default.
• W2078097741 abstract "Epigenetic silencing is a common mechanism to inactivate tumor suppressor genes during carcinogenesis. Enhancer of Zeste 2 (EZH2) is the histone methyltransferase subunit in polycomb repressive complex 2 which mediates transcriptional repression through histone methylation. EZH2 overexpression has been linked to aggressive phenotypes of certain cancers. However, the mechanism that EZH2 played in promoting malignancy in non-small cell lung cancer (NSCLC) remains unclear. In addition, the correlation of EZH2 overexpression and the prognosis of NSCLC patients in non-Asian cohort need to be determined.Up-regulation of EZH2 was found in NSCLC cells compared with normal human bronchial epithelial cells by western blot assay. Upon EZH2 knockdown using small interfering RNA (siRNA), the proliferation, anchorage-independent growth and invasion of NSCLC cells were remarkably suppressed with profound induction of G1 arrest. Furthermore, the expression of cyclin D1 was notably reduced whereas p15(INK4B), p21(Waf1/Cip1) and p27(Kip1) were increased in NSCLC cells after EZH2-siRNA delivery. To determine whether EZH2 expression contributes to disease progression in patients with NSCLC, Taqman quantitative real-time RT-PCR was used to measure the expression of EZH2 in paired tumor and normal samples. Univariate analysis revealed that patients with NSCLC whose tumors had a higher EZH2 expression had significantly inferior overall, disease-specific, and disease-free survivals compared to those whose tumors expressed lower EZH2 (P = 0.005, P = 0.001 and P = 0.003, respectively). In multivariate analysis, EZH2 expression was an independent predictor of disease-free survival (hazard ratio = 0.450, 95% CI: 0.270 to 0.750, P = 0.002).Our results demonstrate that EZH2 overexpression is critical for NSCLC progression. EZH2 mRNA levels may serve as a prognostic predictor for patients with NSCLC." @default.
• W2078097741 created "2016-06-24" @default.
• W2078097741 creator A5006977019 @default.
• W2078097741 creator A5016146359 @default.
• W2078097741 creator A5023135321 @default.
• W2078097741 creator A5032244509 @default.
• W2078097741 creator A5040416714 @default.
• W2078097741 creator A5065373099 @default.
• W2078097741 creator A5068028253 @default.
• W2078097741 creator A5073910378 @default.
• W2078097741 creator A5075931431 @default.
• W2078097741 date "2012-12-31" @default.
• W2078097741 modified "2023-10-05" @default.
• W2078097741 title "EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer" @default.
• W2078097741 cites W1481014355 @default.
• W2078097741 cites W1965890236 @default.
• W2078097741 cites W1976235285 @default.
• W2078097741 cites W1976626368 @default.
• W2078097741 cites W1978316906 @default.
• W2078097741 cites W1989636291 @default.
• W2078097741 cites W1993328712 @default.
• W2078097741 cites W1998947396 @default.
• W2078097741 cites W2003916102 @default.
• W2078097741 cites W2004282924 @default.
• W2078097741 cites W2012252035 @default.
• W2078097741 cites W2016167920 @default.
• W2078097741 cites W2021505095 @default.
• W2078097741 cites W2026530445 @default.
• W2078097741 cites W2028101001 @default.
• W2078097741 cites W2037548653 @default.
• W2078097741 cites W2038676786 @default.
• W2078097741 cites W2039948198 @default.
• W2078097741 cites W2050419281 @default.
• W2078097741 cites W2053421436 @default.
• W2078097741 cites W2057065967 @default.
• W2078097741 cites W2062586342 @default.
• W2078097741 cites W2064422408 @default.
• W2078097741 cites W2071141495 @default.
• W2078097741 cites W2071988722 @default.
• W2078097741 cites W2085932408 @default.
• W2078097741 cites W2095950601 @default.
• W2078097741 cites W2096065464 @default.
• W2078097741 cites W2100046750 @default.
• W2078097741 cites W2100365251 @default.
• W2078097741 cites W2109388391 @default.
• W2078097741 cites W2114318954 @default.
• W2078097741 cites W2117305571 @default.
• W2078097741 cites W2117904693 @default.
• W2078097741 cites W2121737942 @default.
• W2078097741 cites W2127684282 @default.
• W2078097741 cites W2128064256 @default.
• W2078097741 cites W2132313903 @default.
• W2078097741 cites W2137894910 @default.
• W2078097741 cites W2159742844 @default.
• W2078097741 cites W2159815377 @default.
• W2078097741 cites W2165948908 @default.
• W2078097741 cites W2171449084 @default.
• W2078097741 doi "https://doi.org/10.1371/journal.pone.0052984" @default.
• W2078097741 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3534094" @default.
• W2078097741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23300840" @default.
• W2078097741 hasPublicationYear "2012" @default.
• W2078097741 type Work @default.
• W2078097741 sameAs 2078097741 @default.
• W2078097741 citedByCount "68" @default.
• W2078097741 countsByYear W20780977412013 @default.
• W2078097741 countsByYear W20780977412014 @default.
• W2078097741 countsByYear W20780977412015 @default.
• W2078097741 countsByYear W20780977412016 @default.
• W2078097741 countsByYear W20780977412017 @default.
• W2078097741 countsByYear W20780977412018 @default.
• W2078097741 countsByYear W20780977412019 @default.
• W2078097741 countsByYear W20780977412020 @default.
• W2078097741 countsByYear W20780977412021 @default.
• W2078097741 countsByYear W20780977412022 @default.
• W2078097741 countsByYear W20780977412023 @default.
• W2078097741 crossrefType "journal-article" @default.
• W2078097741 hasAuthorship W2078097741A5006977019 @default.
• W2078097741 hasAuthorship W2078097741A5016146359 @default.
• W2078097741 hasAuthorship W2078097741A5023135321 @default.
• W2078097741 hasAuthorship W2078097741A5032244509 @default.
• W2078097741 hasAuthorship W2078097741A5040416714 @default.
• W2078097741 hasAuthorship W2078097741A5065373099 @default.
• W2078097741 hasAuthorship W2078097741A5068028253 @default.
• W2078097741 hasAuthorship W2078097741A5073910378 @default.
• W2078097741 hasAuthorship W2078097741A5075931431 @default.
• W2078097741 hasBestOaLocation W20780977411 @default.
• W2078097741 hasConcept C104317684 @default.
• W2078097741 hasConcept C119056186 @default.
• W2078097741 hasConcept C121608353 @default.
• W2078097741 hasConcept C126322002 @default.
• W2078097741 hasConcept C143998085 @default.
• W2078097741 hasConcept C150425827 @default.
• W2078097741 hasConcept C173396325 @default.
• W2078097741 hasConcept C199835354 @default.
• W2078097741 hasConcept C22615655 @default.
• W2078097741 hasConcept C2776256026 @default.
• W2078097741 hasConcept C29537977 @default.
• W2078097741 hasConcept C41091548 @default.

• next